Get the Stockscreener App
4.05
0.00%
0.00
After Hours:
4.12
0.07
+1.73%
Bionano Genomics Inc stock is traded at $4.05, with a volume of 85,361.
It is up +0.00% in the last 24 hours and up +16.71% over the past month.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.
See More
Previous Close:
$4.05
Open:
$4.05
24h Volume:
85,361
Relative Volume:
0.44
Market Cap:
$14.49M
Revenue:
$36.12M
Net Income/Loss:
$-232.49M
P/E Ratio:
-0.2278
EPS:
-17.78
Net Cash Flow:
$-126.87M
1W Performance:
-7.95%
1M Performance:
+16.71%
6M Performance:
-79.29%
1Y Performance:
-91.73%
1-Day Range:
$4.00
$4.2271
1-Week Range:
$3.96
$5.22
52-Week Range:
$2.68
$72.60
Bionano Genomics Inc Stock (BNGO) Company Profile
Name
Bionano Genomics Inc
Sector
Industry
Phone
(858) 888-7600
Address
9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA
Compare BNGO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BNGO
Bionano Genomics Inc
|
4.05 | 14.49M | 36.12M | -232.49M | -126.87M | -17.78 |
|
ISRG
Intuitive Surgical Inc
|
482.74 | 175.60B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
198.71 | 59.07B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
92.54 | 44.80B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
212.91 | 31.51B | 4.93B | 1.25B | 1.38B | 8.47 |
|
COO
The Cooper Companies, Inc.
|
79.51 | 15.75B | 3.90B | 392.30M | 288.10M | 1.95 |
Bionano Genomics Inc Stock (BNGO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-15-24 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Sep-10-24 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-05-23 | Initiated | Scotiabank | Sector Outperform |
| Dec-12-22 | Resumed | BTIG Research | Buy |
| Jul-18-22 | Resumed | Oppenheimer | Outperform |
| Jun-16-21 | Initiated | BTIG Research | Buy |
| Sep-24-20 | Initiated | Ladenburg Thalmann | Buy |
| Apr-08-20 | Initiated | Oppenheimer | Outperform |
View All
Bionano Genomics Inc Stock (BNGO) Latest News
Bionano Genomics (BNGO) Projects Stable Revenue Growth for 2025 - GuruFocus
Bionano Genomics (BNGO) Sees Revenue Upgrade Despite Lower Price Target - GuruFocus
Bionano Genomics (BNGO) Faces Revenue Growth, Missed EPS Targets - GuruFocus
Bionano Genomics (BNGO) Advances Multiple Myeloma Analysis - GuruFocus
Bionano Genomics (BNGO) Reports Q4 2024 Earnings: Revenue Decline but Margin Improvement - GuruFocus
HC Wainwright & Co. Initiates Coverage of Bionano Genomics (BMV:BNGO) with Buy Recommendation - Nasdaq
HC Wainwright & Co. Initiates Coverage of Bionano Genomics (LSE:0A4K) with Buy Recommendation - Nasdaq
HC Wainwright & Co. Initiates Coverage of Bionano Genomics (BNGO) with Buy Recommendation - Nasdaq
HC Wainwright Initiates Bionano Genomics With Buy Rating, $10 Price Target - marketscreener.com
Richardson Electronics Q3 2025 Earnings Call Transcript - MarketBeat
Bionano Announces French Publication of an Effective Method for Analysis of Multiple Myeloma by OGM - The Manila Times
Breakthrough: French Study Reveals Game-Changing Multiple Myeloma Detection Method - Stock Titan
(BNGO) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Revenues Working Against Bionano Genomics, Inc.'s (NASDAQ:BNGO) Share Price Following 26% Dive - simplywall.st
Bionano Genomics Inc Reports Q4 Revenue of $8.2 Million, Surpassing Estimates - GuruFocus
Analysts Are Upgrading Bionano Genomics, Inc. (NASDAQ:BNGO) After Its Latest Results - Yahoo Finance
Bionano Genomics Q4 Earnings Call: Mixed Sentiments and Strategic Shifts - TipRanks
Bionano Genomics, Inc. (NASDAQ:BNGO) Q4 2024 Earnings Call Transcript - Insider Monkey
Bionano Genomics Inc (BNGO) Q4 2024 Earnings Call Highlights: Strategic Cost Reductions and ... - Yahoo Finance
Bionano Genomics Inc (BNGO) Q4 2024 Earnings Call Highlights: Strategic Cost Reductions and ... By GuruFocus - Investing.com Canada
Bionano Genomics Reports 2024 Financial Results - TipRanks
Bionano Genomics outlines 2025 revenue guidance of $29M-$32M with strategic focus on utilization - MSN
Bionano Genomics (BNGO) Q4 2024 Earnings Call Transcript - Yahoo Finance
Bionano Genomics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: Bionano Genomics Q4 2024 sees revenue drop By Investing.com - Investing.com South Africa
Earnings call transcript: Bionano Genomics Q4 2024 sees revenue drop - Investing.com
Bionano Genomics, Inc. SEC 10-K Report - TradingView
Bionano Reports Fourth Quarter and Full-Year 2024 Results and Provides Revenue Outlook for 2025 - The Manila Times
Bionano Genomics Reports Q4 and Full-Year 2024 Results - TradingView
Stock Market Correction: 2 Warren Buffett Stocks to Buy Hand Over Fist - The Globe and Mail
Bionano Genomics Inc expected to post a loss of $6.00 a shareEarnings Preview - TradingView
SoFi Stock Is Down 23% YTD. Should You Buy the Dip or Stay Away? - The Globe and Mail
What's Next: Bionano Genomics's Earnings Preview - Benzinga
Q4 Earnings Outperformers: Fastenal (NASDAQ:FAST) And The Rest Of The Maintenance and Repair Distributors Stocks - The Globe and Mail
Hakluyt appoints Ronald Sugar to its International Advisory Board - The Globe and Mail
BNGO stock touches 52-week low at $3.15 amid market challenges By Investing.com - Investing.com South Africa
BNGO stock touches 52-week low at $3.15 amid market challenges - Investing.com Australia
LYFT Stock Gains as Activist Investor Engine Capital Builds Stake - The Globe and Mail
Bionano Genomics and Greenwood Genetic Center Publish Study Using Optical Genome Mapping to Advance Understanding of Neural Tube Defects - Nasdaq
Study Using OGM in Neural Tube Defects Reveals Previously Unreported Variants and Candidate Genes with Potential Links to the Devastating Birth Defect - The Manila Times
Major Discovery: New Genes Linked to Birth Defects Found Using Advanced DNA Mapping - StockTitan
3 Services Stocks Skating on Thin Ice - The Globe and Mail
BNGO stock touches 52-week low at $3.28 amid market challenges - Investing.com Australia
BNGO stock touches 52-week low at $3.28 amid market challenges By Investing.com - Investing.com South Africa
Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) 2025 Annual Meeting - The Manila Times
Leading Experts Validate Bionano's Genome Mapping Technology at Major Medical Conference - StockTitan
(BNGO) Technical Data - Stock Traders Daily
Bionano to Report Fourth Quarter and Full Year 2024 Financial Results and Host a Conference Call Webcast on March 31, 2025 - The Manila Times
Bionano Genomics Inc Stock (BNGO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.90%
3.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):